Evaluation of [89Zr]Zr-girentuximab PET imaging of clear cell renal cell carcinoma in Chinese patients: a Phase 1 clinical study (ZIRDOSE-CP)

Abstract Background Results from a multinational Phase 3 study demonstrated high accuracy and a favorable safety and tolerability profile of [89Zr]Zr-girentuximab PET for detection and characterization of clear cell renal cell carcinoma (ccRCC). However, [89Zr]Zr-girentuximab has not been studied in...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Chen Liu, Yongpeng Ji, Xiaoyan Wu, Brenda Cerqueira, David Cade, Peng Du, Zhi Yang
Formato:	Artigo
Idioma:	Inglês
Publicado em:	SpringerOpen 2025-12-01
coleção:	EJNMMI Research
Assuntos:	Renal cell carcinoma Carbonic anhydrase IX Positron emission tomography Radiopharmaceuticals [89Zr]Zr-girentuximab
Acesso em linha:	https://doi.org/10.1186/s13550-025-01332-5
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!